Molex Archives - Medical Design Sourcing

Molex opens new Phillips-Medisize manufacturing facility

Molex — owned by Koch Industries — already has plans to expand its new Phillips-Medisize facility in Katowice, Poland.[Image courtesy of Molex]

Molex today announced the opening of a new campus in Katowice, Poland, for Phillips-Medisize, its medical device contract development and manufacturing organization subsidiary.

The facility has 23,000 m² of manufacturing space, and Molex plans to later expand the facility to as much as 85,000 m².

Molex — owned by Wichita, Kansas-based Koch Industries — said it has invested $110 million in the campus. It will initially support Phillips-Medisize with production of pharmaceutical, medical and diagnostic devices.

The first facilities on the campus will have around 350 employees at planned capacity, including highly skilled production operators, design engineers and quality specialists, Molex said..

“The Katowice campus will expand our European foo…

Phillips-Medisize and Modular Medical partner on insulin delivery alternatives

Phillips-Medisize designed and developed manufacturing and assembly for Modular’s MODD1 insulin delivery system. [Image courtesy of Modular Medical]

NEWS RELEASE: Modular Medical Partners with Phillips-Medisize to Expand Insulin Delivery Alternatives Modular Medical, Inc. (Nasdaq:MODD), a development stage insulin delivery technology company seeking to launch the next generation of user-friendly and affordable insulin pump technology, today announced a collaboration under which Phillips-Medisize, a Molex company and a leader in the design, engineering and manufacturing of pharmaceutical drug delivery, invitro diagnostic, medtech and specialty consumer devices, is providing Modular Medical with design, development and high-volume manufacturing capabilities.

Phillips-Medisize leveraged its global, diversified supplier base and deep medical device and diabetes disease experience to desi…

Phillips-Medisize unveils new disposable injector pen

[Image courtesy of Phillips-Medisize]

Phillips-Medisize, a Molex company, announced today that it expanded its product portfolio with a new disposable pen injector.

Hudson, Wisconsin-based Phillips-Medisize designed the new injector for high-volume manufacturing. It intends to offer pharmaceutical companies a familiar, competitive pen injector for faster, more efficient and cost-effective market entry.

Get the full story at our sister site, Drug Delivery Business News.

Phillips-Medisize unveils new disposable injector pen

The newly unveiled disposable pen injector. [Image courtesy of Phillips-Medisize]Phillips-Medisize, a Molex company, announced today that it expanded its product portfolio with a new disposable pen injector.

Hudson, Wisconsin-based Phillips-Medisize designed the new injector for high-volume manufacturing. It intends to offer pharmaceutical companies a familiar, competitive pen injector for faster, more efficient and cost-effective market entry.

The company plans to display the pen at Pharmapack Europe, according to a news release.

“A pen injector is an important addition to Phillips-Medisize’s expanding product and platform portfolio that empowers biopharma companies to accelerate the rollout of novel and generic drug treatments at significant economies of scale,” said Paul Chaffin, SVP and president of medical and pharmaceutical solutions, Molex. “This ‘ready to go’ solution offers all of the advantages expected from ‘state of the art’ pen designs while be…

Most pharma executives see digital drug delivery as important, Molex says

A survey conducted by Molex and its Phillips-Medisize medical device delivery division highlights the importance of digitized drug delivery.

Lisle, Ill.-based Molex and Phillips-Medisize commissioned Dimensional Research to poll 215 qualified pharmaceutical professionals who are all stakeholders in a range of digital drug delivery devices, according to a news release.

Get the full story at our sister site, Drug Delivery Business News.

Molex taps former Ecolab SVP to run its medical business, including Phillips-Medisize

Paul Chaffin, SVP of Molex’s Medical and Pharmaceutical Solutions division

Paul Chaffin — most recently SVP of enterprise initiatives at Ecolab — has become SVP in charge of Molex’s Medical and Pharmaceutical Solutions division, including contract manufacturing giant Phillips-Medisize.

Chaffin will report to Molex CEO Joe Nelligan and will be a member of the company’s Global Leadership Team.

“Paul’s depth of healthcare, commercial and international experience combined with his strong leadership skills will be a big asset to not only our medical business but to the Molex leadership team. We’re confident that Paul will help fulfill our vision of expanding our global footprint with innovative and digitally connected medical solutions at a time when delivering top-quality care to patients around the world is so critical,” said Joe Nelligan, CEO of Molex.

Chaffin described the combined…